Home/Filings/4/0000899243-20-032576
4//SEC Filing

Hodges Philip 4

Accession 0000899243-20-032576

CIK 0001326190other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 7:05 PM ET

Size

8.9 KB

Accession

0000899243-20-032576

Insider Transaction Report

Form 4
Period: 2020-11-30
Transactions
  • Sale

    Common Stock, par value $0.0001

    2020-12-01$13.54/sh1,227$16,6140 total(indirect: See Footnote)
  • Sale

    Common Stock, par value $0.0001

    2020-11-30$12.00/sh2,500$30,00014,731 total
Holdings
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    17,848
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.51 to $13.59, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The shares of Common Stock are owned directly by Redmont Venture Partners, Inc. The reporting person has sole voting and dispositive control with respect to all securities held by Redmont Venture Partners, Inc. and may be deemed to be the beneficial owner of the securities held by Redmont Venture Partners, Inc. The reporting person disclaims beneficial ownership of the securities held by Redmont Venture Partners, Inc. except to the extent of his pecuniary interest therein.
  • [F4]The shares of Common Stock are owned directly by Paradigm Venture Partners, L.P. The reporting person has sole voting and dispositive control with respect to all securities held by Paradigm Venture Partners, L.P. and may be deemed to be the beneficial owner of the securities held by Paradigm Venture Partners, L.P. The reporting person disclaims beneficial ownership of the securities held by Paradigm Venture Partners, L.P. except to the extent of his pecuniary interest therein.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001705562

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 7:05 PM ET
Size
8.9 KB